A new expert panel has been formed to evaluate pain management in canine osteoarthritis following a recent shift to a more integrated approach to pain and disease research.
In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Over the last few years, however, it has become increasingly apparent that the relationship is far more complex and that pain may be a driver of disease rather than just a consequence of it. The expert panel hopes to apply the new knowledge to the management of joint pain in veterinary practice.
The panel, which had its inaugural meeting in Paris recently, brings together acknowledged veterinary experts in the fields of pain and joint disease. Its focus will be on the assessment and management of pain in canine osteoarthritis (OA), with the objective of educating veterinary surgeons to better understand and manage pain in canine OA and thereby improve the well-being of pets that suffer from this common disease.
'Central sensitisation' is one of the latest theories that has been suggested to explain the complex interaction between pain and disease progression in canine OA. Duncan Lascelles, Associate Professor of Surgery at North Carolina State University, said that research has shown that the components of the pain pathway can change in response to a pain stimulus. Pain receptors 'up-regulate' in response to painful stimuli and become more sensitive to subsequent pain.
CNS sensitisation is likely a significant contributor to chronic or maladaptive pain; this pain leads to decreased mobility, reduced muscle support and reduced muscle function, thus leading to disease progression. In other words, joint diseases cause pain, which in turn feeds back to create more disease.
Professor Lascelles said: "The link between the clinical signs associated with OA and joint pathology is not a simple one and may be much more complex than we have previously thought.
"There is some evidence that COX inhibition reduces central sensitisation. And some evidence suggests that reducing central sensitisation may have a modulatory effect on disease progression by reducing signals going out to the periphery.
"The relationship between pain and disease progression is a very new area of research, and is at the forefront of our knowledge of how pain and joint disease are linked."
Professor John Innes, Head of Division, Small Animal Studies, University of Liverpool Veterinary School, told the meeting that OA is likely to be one of the major reasons for euthanasia of pet dogs in Europe. He and two co-investigators have performed a systematic review of the published evidence for the use of long-term, continuous NSAID treatment (at least 28 days) in OA. They found that this form of management is associated with better outcomes than short-term NSAID therapy, with no evidence of additional safety issues. This review is to be published shortly.
The expert panel comprises:
Prof Dr Stuart Carmichael, Vets Now Ltd. Formerly at: Veterinary School, University of Glasgow, UKProf Dr John Innes, Small Animal Teaching Hospital, University of Liverpool, UKDr Bernard Bouvy-Centre, Hospitalier Vétérinaire de Frégis, Arcueil, FranceProf Dr Jean-Pierre Genevois, Ecole Nationale Vétérinaire de Lyon, FranceDr Carlos Macías, Centro Veterinario de Referencia Bahia de Malaga, SpainProf Dr Martin Kramer, Klinik für Kleintiere, Chirurgie , Justus-Liebig-Universität Gießen, GermanyDr Sabine Tacke, Klinik für Kleintiere, Chirurgie, Justus-Liebig-Universität GießenProf Dr Duncan Lascelles, North Carolina State University College of Veterinary Medicine, Raleigh, USAProf Dr Herman A.W. Hazewinkel, Faculteit Diergeneeskunde, Departement Gezelschapsdieren, Utrecht, NetherlandsDr Emilio Feltri, Anaesthetist and specialist in Pain Management, Ambulatorio Veterinario Associato, Tortona, ItalyDr Peter Vandekerckhove, Specialist Surgeon Companion Animal, Wondelgem, Belgium
Fort Dodge Animal Health has announced that its Duvaxyn WNV vaccine against West Nile Virus (WNV) is now available in the UK, following its licensing through the European Medicines Agency (EMEA).
Duvaxyn WNV is the first vaccine available in Europe to protect horses against this emerging disease threat. 288 horses and two people in Italy were found to be infected with WNV during the outbreak that hit northern Italy in late 2008 where it is now considered endemic. The disease is endemic in all areas of North America where it has claimed the lives of both horses and humans.
West Nile Virus is caused by a highly contagious flavivirus, which is transmitted by mosquitoes, primarily of the Culex species. The natural hosts of West Nile virus are birds, with migratory birds from Africa carrying the disease. Mosquitoes become infected after taking a blood meal from infected birds and then may transmit the disease to horses and even humans. While horses are 'dead end hosts,' the consequences can be severe as the virus causes encephalitis or meningitis. Mortality rates among horses which develop neurological signs are high and there is no palliative cure for the disease. Treatment is limited to symptomatic relief which can be long and expensive.
Sabrina Jordan, UK Business Manager for Equine Vaccines at Fort Dodge said: "WNV is an increasing threat to the equestrian sector in the UK and is a particular challenge for owners who transport their horses around the world.
"The fact that a vaccine is now available will undoubtedly offer peace of mind to the equestrian community. They can be reassured that horses in the UK can now be vaccinated against WNV with a vaccine that has already been shown to be highly effective in protecting horses in America.
"With any vaccine, a record that a horse has been vaccinated with Duvaxyn WNV should be recorded in its horse passport. By presenting this vaccine in pre-filled syringes with Infovax-ID labels, we've aimed to make both the administration and record keeping of Duvaxyn WNV as convenient as possible.
"To build understanding of this potentially fatal disease threat, we are continuing to work with governments and authorities at a national and European level, as well as working in partnership with the UK's veterinary community to ensure that owners are fully informed about the risk WNV poses and of the benefits of vaccination."
VetSurgeon is sad to report that Sam Duff, a much loved figure in the profession, died last weekend.
Sam qualified from Edinburgh in 1970, and was a partner in mixed practice in Fife until 2002. More recently, he was a director of Equitique Ltd, an equine reproduction referral practice.
Sam was an active member of BVA Council, and its Member Services Group. He served on SPVS Council from 1993-2002, and was re-elected in 2003. He had recently been elected as Secretary of the Scottish branch of the BVA.
A memorial service will be held at 2.30pm on Thursday 9th July in Younger Hall, St Andrews.
Vetoquinol has announced the launch of Enisyl-FTM, the first L-Lysine supplement developed for veterinary use in the UK and Ireland.
Vetoquinol says a unique distributing pump and paste formulation will aid compliance in cats that require L-Lysine supplementation and make administration of L-Lysine much easier. Each pump action delivers 1ml of Enisyl-F paste at each press, which can be applied directly into the cat's mouth or on the paw to be licked off. It can also be added to food.
Zorica Agbaba, Enisyl-F's Product manager said: "We are delighted to have launched Enisyl-F and I am sure it will prove very useful to veterinary surgeons, especially when it comes to aiding compliance in cats that require L-Lysine supplementation."
To try Enisyl-F or for more information about the product, contact your local Vetoquinol representative or call Vetoquinol main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number). Alternatively visit http://www.vetoquinol.co.uk/ website.
Animals Count, which describes itself as a political party for people and animals, will launch its EU election manifesto on 24th May from 12 noon at the Kings Oak, Loughton, where it will be putting into practice one of its proposed policies: subsidised basic and emergency animal health care for animals. Animals Count President and veterinarian, Andrew Knight, will provide free dog consultations and animal health care advice for all companion animals.
Animals Count will contest the European Parliament elections, taking place on the 4th of June. It hopes to end farming with poor welfare consequences for animals, long distance live animal transport, all hunting for sport, and introduce an EU-wide subsidised basic animal health care system.
Animals Count Leader, Jasmijn de Boo MSc., said: "Concern for animals has long been a mainstream priority, yet remains poorly represented by most political parties. In several countries political parties for animals have formed to meet this need. The Dutch Party for the Animals from which we grew now has 20 elected representatives, including 2 MPs and one senator."
"The EU elections are particularly important for people and animals. Around half the EC budget is spent on agriculture. Given today's economic climate there's never been a better time to re-examine the massive expenditure of tax-payer money on farming methods known to be strongly associated with poor animal welfare and serious environmental damage."
Miss de Boo, 33, Alex Bourke, 47, Vice-chair of Animals Count and best-selling author of the 'Vegetarian Guides' book series, and Richard Deboo, 41, City professional and public speaker on animal issues, will contest the June EU elections in the Eastern region of the UK. Animals Count's ultimate goal is a world in which animals are not exploited, and are treated as sentient beings.
Abbott Animal Health is launching GLUture Topical Tissue Adhesive this month.
Abbott says GLUture is an Octyl/Butyl cyanoacrylate blend that creates a strong and flexible bond that contours to the wound site. GLUture applies purple for visibility and dries clear for a neat cosmetic appearance. Offered in an economical multi-use package with 10 applicators, GLUture's viscosity and applicator design enable flow-controlled application. GLUture topical tissue adhesive offers a flexible seal, quick application and a strong bond.
For more information, ring Abbott on 01628 644354, or visit: www.abbottanimalhealth.com
Intervet/Schering-Plough Animal Health has launched a new consumer campaign to support the company's joint care supplement, Cosequin.
The campaign centres around a series of paw-tapping internet videos which showcase the perfectly poised paws of dog and cat dance duo, Fred and Ginger, highlighting the importance of good joint health. The videos are available to view at http://www.cosequin-dance.co.uk/
Pet owners are encouraged to purchase Cosequin from vet practices to enter a prize draw to win a photography day with leading animal photographer, Sam Lunt, or one of ten tickets to an upcoming live dancing tour. Posters and in-practice leaflets are also available for vet practices to help drive awareness and encourage uptake.
Sarah-Jane Minter, Marketing Manager for Intervet/Schering-Plough, commented; "We wanted to create a campaign which would support vets in practice and attract the attention of pet owners, especially those who may not have previously thought about the joint health of their pet. With these lighthearted new videos of Fred and Ginger demonstrating everything from the jive to the rumba and an eye-catching print campaign, we certainly expect to grab pet owners' attention!"
ISPAH says that by supporting joint condition and maintaining not only healthy cartilage, but also healthy joint structures, Cosequin is suitable for all dogs and cats that need some joint support, especially highly active or older animals. It adds that the joint care supplement contains 100% pure chondroitin sulphate and the unique formulation has been proven in over 50 clinical trials.
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Referral Centre VRCC reports that its first Small Animal Veterinary Education Conference Weekend in Kenya, held in November and supported by Merial, has been a great success. Over 30 East African vets from all over Kenya gathered at the elegant Leopard Beach Hotel, just south of Mombasa, to learn from some of the leading specialists in the UK.
The Kenyans, all with an interest in small animals, were a real cross section of the African profession. They ranged from prosperous vets with large practices in Nairobi to a young vet who'd undertaken a gruelling 7 hour bus ride accompanied by armed guards from his clinic on Lamu, near the Somali border.
A challenging 2 day programme had been devised by VRCC specialists including Dr Susan North, one of the most experienced and highly qualified veterinary oncologists in Europe and also a European Specialist in Internal Medicine. Also lecturing were VRCC's Head of Surgery, Henry L'Eplattenier and Merial's Dr Hein Hesse, an expert in pain management and parasite control. The weekend finished with a prolonged question and answer session with the enthusiastic delegates hungry to gain as much knowledge as possible from the visiting specialists before their long journey home.
Malcolm Holland at VRCC was delighted with the first time turn-out at the conference. He said: "The Conference Weekend was successful on so many fronts. The delegates had access to first-hand information not readily available to them - the last lecturing team visited over 20 years ago! They were able to interact with each other, form networks, and renew friendships.
"VRCC was not seeking any material gain, just fulfilling a desire to pass on some of our experience for the improved welfare of small animals in East Africa."
VRCC expects attendance to more than double now Kenyan vets know that commitments will be fulfilled. Specialists keen to participate in future events or companies with interests or ambitions in Kenya should contact Malcolm Holland at VRCC.
The Kennel Club has confirmed that the BBC has pulled out of broadcasting Crufts next year.
According to the Kennel Club, the decision was reached following what it described as 'unreasonable demands' from the BBC, including the exclusion of certain breeds of dog from the group competition at the show.
The Kennel Club says the BBC's demands took no account of the measures it has in place to improve the health of pedigree dogs, or of the fact that judges will be trained to help ensure that all dogs being awarded prizes at Crufts will be healthy representatives of their breed.
Ronnie Irving, Kennel Club Chairman, said "I am very sorry that BBC audiences around the world will not be able to join us in celebrating all dogs in 2009 and to see the remarkable diversity of dogs and activities on show at Crufts; ranging from the show classes to agility displays, the Friends for Life competition and the unsung heroes who take part in breed rescue.
"However, we have been forced to reject the insupportable conditions imposed by the BBC, who have told us they will only televise the show in 2009 if certain breeds are excluded from participating.We are unable to agree to these demands, as it would compromise both contractual obligations and our general responsibility to dog exhibitors and our audience and we believe it would be inappropriate and counterproductive to exclude any recognised breed from Crufts.
"We are obviously disappointed and confused with this outcome as we hoped the broadcast would have supported our focus on health and welfare issues, given advice about caring for and training dogs and showcased the charitable work that we support. This TV exposure would have benefited all dogs and given viewers a well-rounded picture of what the new Crufts in 2009 is all about."
In October 2008 the Kennel Club announced a strategy to show how it is focusing its activities on the health and welfare of all dogs. It announced mandatory compliance with a strict code of ethics for all breed clubs registered with the Kennel Club.
Earlier this month, it completed a review for each of the 209 pedigree dog breeds in the UK and announced revised standards that it says will have far-reaching benefits for the health and welfare of dogs. These new breed standards and health plans will benefit from research that has been funded by the Kennel Club in conjunction with veterinary research centres over a number of years. The overall aim is that all pedigree dogs should be fit for function and that breeders and judges should not reward dogs with obvious conditions or exaggerations, which would be detrimental in any way to their health.
The results of a new study1 highlighting the prevalence of Angiostrongylus vasorum infection as seen by UK veterinary surgeons, combined with the low awareness amongst dog owners of this parasite2 has led Bayer Animal Health to launch a nationwide 'Be Lungworm Aware' initiative.
Backed by a hard-hitting national advertising, PR and radio campaign which kicks off in April, the initiative aims to highlight the prevalence of this potentially, and often fatal infection, and to drive pet owners to their veterinary practices for further information.
The initiative also sees the launch of a new educational website for dog owners - http://www.lungworm.co.uk/. The site offers further information on the infection, including likely signs, how to obtain treatment and a video of the lifecycle of the parasite showing the threat posed by the lungworm's intermediate hosts - slugs and snails.
The study revealed that 16% of vets questioned had one or more confirmed cases of the disease. A further 10% had seen dogs that they suspected had the infection. However, only 6% of dog owners questioned in a UK wide survey had unprompted awareness of the parasite.
Bayer's Chris White said: "These results are no surprise following the reports last year of confirmed cases of Angiostrongylus vasorum as far north as Glasgow. The disease has seen a rapid rise in importance over the past few years highlighted by the number of vets and nurses that attended the Advocate CPD meetings held around the country at the end of last year.
"The 'Be Lungworm Aware' initiative aims to educate owners on the risks associated with infection, to encourage them to visit their vet for further information and discuss their dogs' parasite protection plan."
For further details, or to order the supporting practice materials, including a new educational waiting room display and practice PR pack to help raise awareness locally, please contact your Bayer representative or ring 01635 563682.
1Insight Track, 2008 2Insight Track, 2009
Guernsey-based vet, VetSurgeon member David Chamberlain has officially launched a revolutionary cat flap which synchronises with a cat's microchip to control access to the house. The Pet Porte Microchip Cat Flap is the first cat flap that works in conjunction with microchips and has already been winning awards.
Aside from allowing only the homeowner's cats into the house, the Pet Porte Microchip Cat Flap has a number of other interesting features. ‘Vet Mode' allows recognised cats in, but does NOT allow them out, useful when a trip to the vet is on the calendar. ‘Night Mode' uses an automatic daylight sensor to lock the door as ambient light levels drop, keeping cats inside and safe. An audible beep (which can be turned off) provides an alert when a programmed cat enters though the flap.
The Pet Porte Microchip Cat Flap recognises 15 digit UK/European FDX-B microchips. Owners of cats that have already beed chipped can check check compatibility with the Pet Porte's 'Chip Checker'.
The cat flap can recognise up to 32 microchipped cats, and programming it is very simple. When the unit is first installed, the owner holds down a green paw button for ten seconds and passes their cat under the porch for the microchip to be programmed into the system.
A review on Pet Porte's website caught my eye:"Just like to say how absolutely fabulous the cat flap is. I've slashed my cat food bill now I'm not feeding the entire street!" On top of that, as Pet Porte says, this system also encourages microchipping, an important part of responsible pet ownership.
The Pet Porte microchip cat flap is currently being marketed in the UK through veterinary practices and online from http://www.petporte.com/. For all sales enquiries call 01481 265 359, email sales@petporte.com or visit www.petporte.com.
Alternatively, 'Start a Conversation' directly with David by clicking the link on his VetSurgeon profile.
Intervet/Schering-Plough Animal Health has announced the launch of Nuflor Minidose - a 50% more concentrated, but less viscous solution of its proven Nuflor antibiotic.
Nuflor Minidose is licensed for the treatment and prevention of bacterial BRD. Intervet/Schering-Plough Animal Health livestock veterinary adviser Rosemary Booth MRCVS said: "It delivers all the rapid efficacy entrusted in Nuflor, but at a lower volume. Whereas a 20ml dose of Nuflor will treat a 150kg animal, the same volume of Nuflor Minidose will cover a 225kg beast. Compared with Nuflor, the new Minidose formulation is easier to administer delivering a less viscous florfenicol solution, with a 62% improvement in viscosity at 15°C and 59% at 5°C."
Rosemary added that Nuflor Minidose is effective against the main bacterial causes of pneumonia: P. multocida, M. haemolytica and H. somni. "Florfenicol is the only antibiotic offering 100% sensitivity to these three key BRD causes in recent trials and its kill effect also ensures that within 24 hours bacteria levels are low enough to prevent any re-growth."
She also pointed out that the new, more concentrated florfenicol solution presents vets with an improved batch treatment option for controlling BRD considering Nuflor is recognised as an effective metaphylactic
"Batch treatment prevents BRD from spreading. Trials with Nuflor have demonstrated the benefit of metaphylactic batch treatment of sick calves in a pen once at least 20% of the animals exhibit disease symptoms. Nuflor was significantly more efficacious than a control in preventing the spread of BRD in healthy calves exposed to infected animals," she explains.
"The bacteria responsible for BRD are found in the respiratory tract of healthy cattle and stress or a greater pathogen load - such as exposure to sick calves - can easily trigger disease. BRD bacterial numbers can double every 30 minutes and in 24 hours, one bacterium can multiply to billions. Batch treatment kills the bacteria before they multiply, release toxins and cause permanent lung damage."
New Nuflor Minidose is licensed for injection subcutaneously for the prevention of BRD at a dose rate of 4ml/45kg and has a 64-day meat withdrawal period.
SPVS is leading a ground-breaking new project which aims to find out how veterinary surgeons are treating a range of clinical conditions.
Two hundred practitioners are being sought to provide details of how they address clinical conditions in three study areas: small animal, equine and farm animal, on a new website: www.howdoido.org. The findings, which will be made anonymous, will eventually form the basis of a clinical benchmarking process, which will tie in with the growing trend towards evidence-based medicine.
SPVS's objective is to understand and support how clinicians work in practice and approach particular clinical cases. The Society is working alongside Dr Mark Johnson who carried out the Confidential Enquiry into Perioperative Equine Fatalities.
SPVS Junior Vice President Jacqui Molyneux said: "This is an exciting new study which will shed a lot of light on what we as clinicians are doing in practice with the eventual aim of developing a clinical benchmarking process.
"The project however will only be worthwhile if a significant number of practitioners take part, so we're encouraging vets to visit the website and find out more. It will take no longer than ten minutes to fill in each clinical case."
The Soil Association is calling on the Government to issue guidelines that will limit the veterinary use of the most modern penicillin-type antibiotics, to prevent the spread of a serious new superbug.Recently released minutes of a Government committee reveal that Ministers have been briefed about the emergence on a British dairy farm of a mutant strain of antibiotic-resistant E. coli which causes life-threatening cases of food poisoning, including hemorrhagic colitis and haemolytic uraemic syndrome.
The bug, known as E. coli O26 is a vera-toxin producing E. coli (VTEC), similar to the infamous E. coli O157. According to the Soil Association, what makes the discovery of this variant so significant is that this is the first time in the UK, and only the third time in the world, that VTEC E. coli has been found with an enhanced type of antibiotic resistance known as extended-spectrum beta-lactamase (ESBL), which makes it resistant to almost all antibiotics. ESBL resistance has previously been found on 57 UK farms, but until now only in strains of E. coli that cause urinary tract infections and blood poisoning.Although antibiotics are not recommended for the treatment of VTEC E. coli, scientists warn that the emergence of resistance is undesirable because these resistant bacteria are encouraged every time certain antibiotics are used, resulting in increased spread and greater risk of contaminated food products. On non-organic dairy farms, cows are routinely given antibiotics at the end of their lactation to prevent mastitis. In addition, milk from cows given antibiotics for treatment, or prevention, is often fed to calves when it contains residues and cannot be sold. However, because ESBL E. coliO26 is resistant to all the antibiotics used in ‘dry cow therapy' and many of those used for treatment, the high use of antibiotics on dairy farms will promote the rapid spread of these dangerous bacteria.Soil Association Policy Adviser, Richard Young said: "This is one of the most worrying developments in the continuing rise of ESBL E. coli. Today is the first European Antibiotics Awareness Day, but there is a distinct lack of awareness that the continuing high use of antibiotics in farming is contributing to the increase in antibiotic-resistant infections in humans."The Government often calls on doctors to prescribe antibiotics less often. But similar advice needs to be given to veterinary surgeons and farmers. Half of all antibiotics are given to animals, and there is mounting evidence that antibiotic-resistant bacteria in farm animals pass to humans. If we want antibiotics to save lives in the future as they have done in the past then the Government must provide specific recommendations based on scientific advice, and vets need to pull together with doctors to limit the use of problematic drugs."
There are still locum and permanent vacancies in the veterinary industry, despite the current UK recession, but candidates must be prepared to be more flexible, advises veterinary recruitment company, Rig Vet Recruitment.
"The number of vacancies we are being asked to fill at present has not really varied from the same time last year," Said Justin Carpenter, Managing Director of Rig Vets. "But, in these current uncertain times, I would suggest that candidates try to be more versatile in their job requirement criteria on such as location, on-call work, night and weekend duties, working away from home etc, then it will be much easier for us to find them the right positions."
Drontal has renewed sponsorship agreements with councils throughout the UK in a bid to further encourage pet owners to scoop their dogs' poop.
The support will see thousands of council dog bins featuring Drontal branding to promote best practice amongst dog owners and urge them to clean up after their pets.
Dan White, product manager for Drontal, said: "Through our dog bin sponsorship we are highlighting the importance of responsible pet ownership which includes preventing the spread of worm eggs in the environment by scooping poop."
According to Bayer, Drontal is the only wormer that kills every type of intestinal worm commonly found in UK dogs and cats.
For further information please contact your Bayer representative or log on to www.drontal.com.
A survey carried out by CEVA Animal Health, manufacturer of the pheromonatherapy products D.A.P.® and Feliway®, has revealed that 94 per cent of veterinary professionals believe that owners' lifestyles are the major cause of behavioural problems in pets1.
Over three-quarters of those questioned believed that owners should spend more time with their pets to prevent these issues, while 89 per cent thought that owners were too busy to deal with their pets if they developed behavioural problems.
According to CEVA, the fast pace of owners' lifestyles is significantly affecting the stress felt by both dogs and cats and this is further exacerbated in cats by the social demands that pet owners put on them. Cats are solitary survivors that cope better with short, frequent interactions and like their own company. While they are popular for their independence, owners often like to have their pets' full attention when they return from work which is at odds with their cats' preferred behaviour patterns.
Behavioural issues can also result from changes in a pet's environment and new experiences such as moving house, building work, the introduction of a new pet to the household, going to a kennel or cattery, travelling in a car, visiting the vets and stressful events such as Bonfire Night and Christmas. To help combat stress, nearly 65 per cent of dog owners avoid putting their pets in stressful situations, while 19 per cent choose to ignore their stressed dog2.
Lucy Brett, product manager at CEVA Animal Health said: "Our modern lifestyles are leading to stressed pets which, in the long-term, will exacerbate behavioural and medical problems. It's important that veterinary professionals educate their clients on the implications of canine and feline stress to help prevent these issues from developing."
For further information about D.A.P.® and Feliway®, please contact your CEVA Animal Health representative or call CEVA Animal Health on 01494 781510.
Fort Dodge Animal Health has announced that its Zulvac 8 Ovis® Bluetongue sheep vaccine is now licensed and available in the UK. The company believes that the product will provide significant benefits to sheep farmers.
Zulvac 8 Ovis® is an inactivated adjuvanted vaccine for the active immunisation of sheep by subcutaneous injection against Bluetongue Serotype 8. It also provides a reduction in viraemia. Administration is a two x 2 ml dose primary course in year one but only a single shot booster in the second year.
The use of Zulvac 8 Ovis as a booster for animals previously vaccinated with a primary course from other manufacturers is in line with Defra (2009) guidance: 'No problems are anticipated with re-vaccinating animals which have already received a primary course of vaccination with a different vaccine 1'.
The first dose can be administered from one month of age and Zulvac 8 Ovis® is proven for use in pregnant sheep. The onset of immunity is provided 25 days after the second dose.
Fort Dodge says Zulvac provides cost savings to farmers through its pricing strategy. While the price for the two dose primary course is competitive with alternative vaccines, for animals which were vaccinated last year and require only a single shot booster, the cost will be half that of competitive offerings, providing a significant incentive to farmers to vaccinate.
The vaccine is supported by a specific Zulvac Ovis fixed 2ml dose applicator with Sterimatic needle protector and cleaning system which aids administration and hygiene and is sold separately.
David Bartram MRCVS, Veterinary Technical Manager at Fort Dodge, said: "Sheep farmers have been waiting for a Bluetongue vaccine which offers a cost effective solution to vaccination - particularly for animals which received their primary course last year and are simply in need of a booster. We expect the fact that it's licensed for use in pregnant sheep to also prove attractive.
"Zulvac 8 Ovis® is the latest addition to Fort Dodge's Zulvac range for both cows and sheep. It is already used in Europe and has helped protect millions of animals."
I invited Marc Abraham to come and answer some of the concerns raised on VetSurgeon about the ITV Pets Undercover programme.
His PR agency has instead pointed me in the direction of a response he has posted on his own website this morning. Click the link below.
http://www.marcthevet.com/response-to-%e2%80%98pets-undercover%e2%80%99/
The BVA has added its voice to calls for the suspension of imports of cattle and sheep from areas where the bluetongue virus is known to be circulating.
Following yesterday’s announcement by Defra that BTV1 (Bluetongue Serotype 1) had been detected in five cattle imported from a Restricted Zone in the south west of France, BVA President Nicky Paull said: “I am saddened, but not surprised, that the actions of some are putting our livestock here in the UK at risk. As long as some farmers continue to import stock from these areas we will continue to see this problem and we therefore believe that the only answer is to suspend imports. We also see absolutely no reason why compensation should be paid to those who have risked the health and welfare of the national flock and herd.
“My advice to farmers still is to vaccinate against BTV8 if you have not done so already. If you did vaccinate during the summer then plan to boost protection at the end of the winter period so your stock is protected next summer. With no vaccine currently licensed for BTV1 however, do not import livestock from mainland Europe - we should not rely on the hope of a BTV1 vaccine in time to prevent serious problems next summer if we buy this new strain of bluetongue virus into the UK.”
Vets should now consider Angiostrongylus vasorum a countrywide parasite and not one that is restricted to the traditional hotspots of the South East, the Midlands and south Wales. This was the main message delivered by Shelia Brennan of University College Dublin to almost 300 vets attending the recent Bayer-sponsored A vasorum CPD meetings, held across the north of England and Scotland.
Sheila said: "Until recently, angiostrongylosis was only recognised in limited areas of the UK, and confirmed cases were few and far between. Now we are hearing reports of the disease as far afield as Kent and Glasgow and dogs are dying as a result. If caught early enough, the disease can be treated successfully. Vets should be aware of the many and varied symptoms and consider this parasite as a differential in any dog with suspicious clinical signs."
Dogs of any age can be infected with the parasite, but the majority presenting with clinical disease are less than two years of age. A number of clinical presentations are recognised. Dogs may present with respiratory signs (cough, exercise intolerance), coagulopathy, neurological signs, syncope and in a small number of cases hypercalcaemia. These signs can occur in isolation or in combination, and not all dogs have respiratory signs. Haemorrhage following routine neutering has been anecdotally reported. Dogs with a history of eating the parasite's intermediate hosts (slugs and snails) should be considered as being at high risk.
Chris White, Bayer's Advocate product manager said: "The attendance of nearly 300 vets at the four-meeting series, in areas not normally associated with the disease, is further evidence that vets are becoming increasingly concerned about the threat posed by A vasorum. This is the third series of meetings we have held, reaching around 1,000 vets and vet nurses across the country."
Intervet/Schering-Plough Animal Health has launched a new cattle and sheep vaccine which it says gives vets an additional opportunity to prescribe the broadest possible protection against clostridial diseases.
Bravoxin 10 is a low dose clostridial vaccine containing antigens for protection against C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
Dosage volumes are 2ml for cattle and 1ml for sheep and the new vaccine can be used in animals from as young as two weeks old if the dam has not been previously vaccinated. A booster dose pre-calving or lambing will also deliver 8-12 weeks passive immunity in calves and lambs (apart from against C.haemolyticum).
Intervet/Schering-Plough Animal Health ruminant veterinary adviser Rosemary Booth MRCVS said: "Clostridial bacteria take the lives of cattle and sheep on a regular basis and are the cause of a significant proportion of the sudden livestock deaths in this country. In 2007, an independent survey of over 500 UK dairy and beef farmers revealed that half the interviewees had experienced calves or adult cattle dying for no apparent reason. The reality is that many of these losses could have been due to clostridial diseases. Farmer respondents valued the livestock loss at anywhere between £505 and £1243 per animal. Even at the lowest stock valuation, preventing the loss through broad-spectrum vaccination would pay for nearly five years of Bravoxin 10 use in a 100 cow herd.
"Now that additional clostridial pathogens such as C. sordellii and C. perfringens A have been recognised by the VLA and SAC as significant causes of deaths on both cattle and sheep farms, it makes sense to widen pathogen cover on some ruminant livestock units. Bravoxin 10 allows practitioners to prescribe the broadest possible disease protection."
The sheep industry already understands the importance of broad-spectrum vaccination against clostridial diseases, but Iain Carrington from Intake Veterinary Services based in Northumberland believes cattle producers should also upgrade their protection.
"There was a time that clostridial disease control in cattle meant vaccinating your youngstock against blackleg at turnout, or discovering dead animals and then reacting with blackleg vaccine," he said. "But over the last few years, I have seen an increased incidence of different clostridial diseases in far from typical circumstances.
"There are also a large number of cattle deaths going undiagnosed and it is likely that many are caused by clostridial species. As a result, we are now advising many of our clients to take a broader-spectrum vaccination approach to ensure adequate protection - not only of the cows themselves - but also their calves through good colostral transfer," he said.
Bravoxin 10 is a prescription-only medicine (POM-V). For further information, contact the Intervet/Schering-Plough Animal Health Veterinary Support Group on 01908 685685.
It seems that a series of one day conferences, organised by the Animal Health agency for vets and animal health inspectors involved in fighting bovine TB, haven't gone down as well as hoped.
According to a report in yesterday's Daily Telegraph, many in the audience were angered when they were asked to spend up to an hour playing a game involving bongo drums.
Incredibly, a spokesman for Animal Health apparently told the Daily Telegraph that: "It was meant to emphasise how people working together can build up a rhythm."
A new injector gun for administering doramectin-based worm and scab medication to sheep has been introduced by Pfizer Animal Health. According to senior livestock vet Carolyn Hogan, the intra-muscular injection route for this medication combined with the injector’s prime-and-push design allows a single arm movement to penetrate the skin and dispense the treatment.
Marc Abraham MRCVS, the Paul O’Grady Show’s resident vet is setting up a new website for pet owners www.thepet.net, described as being the first to use the power of social networks (think Facebook), to bring pet owners together to share and rate pet experiences, and help each other find the best their pet can get.
I think it'll fly, and if it does, it will be one for many in the profession to keep a close eye on. Reputations can (and have) be made or lost on these kinds of websites.
What's more, previous community sites for pet owners based on the more simple forum model have shown the danger of attracting, well, the nutters. I've seen at least two populated almost entirely by raw meaty bones evangelists firing false (or at least unproven) accusations at everyone from pet food manufacturers to individual vets. Worse than that, the same people seem to advocate alternative therapy for just about every medical condition under the sun. 'Heart failure you say? Wave some of these crystals over its tail'.
I can see pet owners flocking to this kind of site in their hordes. But for it to have any kind of credibility within the profession, I fear Mr Abraham will have to be absolutely ruthless in weeding out those who will inevitably try to use the site as a soapbox for extremist viewpoints. That'll be a challenge. I have first hand experience of just how tenacious some of these people are!